Amgen Inc
(FRA:AMG)
€
283.45
-18.25 (-6.05%)
Market Cap: 150.69 Bil
Enterprise Value: 198.90 Bil
PE Ratio: 38.26
PB Ratio: 21.34
GF Score: 90/100 
Amgen Inc at Cowen Virtual Oncology Innovation Summit Transcript
May 21, 2021 / 03:20PM GMT
Release Date Price:
€206.05
(+1.28%)
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
Well, good morning once again, and thank you for joining us for our second virtual oncology day. I'm Yaron Werber, biotech analyst at Cowen. And it's a great pleasure to moderate the session today with Amgen. The 2 gentlemen here really need no introduction. We have David Reese, who's EVP of R&D; and Arvind Sood, VP of IR. Gentlemen, thanks so much for joining us. We really appreciate it.
Arvind Sood
Amgen Inc. - VP of IR
Good morning.
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
There's lots to talk about, especially the Lakers and the Celtics, but maybe we'll leave that for the last 2 minutes because that's going to be -- that's an ongoing battle.
Questions & Answers
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
So let's start first
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers